Gastric Cancer

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: ctDNA-MRD Monitoring After Resection in Gastric Cancer

  This clinical trial is evaluating ctDNA-based minimal residual disease monitoring after surgical resection in patients with gastric cancer.

• CLINICAL_TRIALS trial_result · 2026-04-20
  Clinical Trial Update: Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer [Phase 1]

  A Phase 1 clinical trial is evaluating the safety and potential efficacy of a leucine-restricted diet in gastric cancer, currently enrolling…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Safety and Efficacy of CT0494BCP in Participants With Advanced Gastric/Esophagogastric Junction Adenocarcinoma

  A clinical trial update describes the planned safety and efficacy assessment of CT0494BCP in adults with advanced gastric or gastroesophagea…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. [Phase 3]

  Phase 3 clinical trial using 18F-FAPI PET imaging to detect metastatic disease in patients with gastric or esophageal cancer; recruitment is…

• CLINICAL_TRIALS other · 2026-04-20
  Clinical Trial Update: A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors [Phase 1]

  Clinical trial update for PF-08046054/SGN-PDL1V in advanced solid tumors shows a Phase 1 study is currently recruiting across multiple indic…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-04-17
  Clinical Trial Update: A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers [Phase 3]

  Phase 3 clinical trial update for zanidatamab in combination with chemotherapy with or without tislelizumab in HER2-positive advanced or met…

• CLINICAL_TRIALS trial_result · 2026-04-17
  Clinical Trial Update: A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies [Phase 1]

  Phase 1 trial of AUR106 in relapsed advanced malignancies has been terminated; the document provides a status update on this study.

• CLINICAL_TRIALS research · 2026-04-17
  Clinical Trial Update: Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer [Phase 2]

  Phase 2 clinical trial evaluating safety and efficacy of a leucine-restricted diet combined with neoadjuvant chemotherapy and immunotherapy …

• CLINICAL_TRIALS research · 2026-04-17
  Clinical Trial Update: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors [Phase 1]

  A Phase 1 clinical trial update for LY4337713 in participants with FAP-positive solid tumors; the study is currently recruiting.

• CLINICAL_TRIALS trial_result · 2026-04-17
  Clinical Trial Update: A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]

  Phase 1b/2 trial of AUR103 calcium in HER2-positive advanced gastric cancer and gastroesophageal junction adenocarcinoma has been terminated…

• CLINICAL_TRIALS research · 2026-04-17
  Clinical Trial Update: Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer [Phase 1, Phase 2]

  A Phase 1/2 study evaluating IDX-1197 in combination with XELOX or Irinotecan for advanced gastric cancer. The trial is currently active but…

• CLINICAL_TRIALS other · 2026-04-17
  Clinical Trial Update: A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors [Phase 1]

  Phase 1 study of BGB-B2033 alone or with tislelizumab, with or without bevacizumab, in adults with advanced or metastatic solid tumors. Indi…

• CLINICAL_TRIALS research · 2026-04-17
  Clinical Trial Update: Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and Immunotherapy in Advanced Gastric Cancer [Phase 2]

  Phase 2 clinical trial evaluating a leucine-restricted diet in combination with chemotherapy and immunotherapy for advanced gastric cancer, …

• CLINICAL_TRIALS trial_result · 2026-04-16
  Clinical Trial Update: Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer [Phase 1]

  A Phase 1 clinical trial evaluating cord blood-derived CAR-NK cells in gastric cancer and pancreatic adenocarcinoma has completed status and…

• CLINICAL_TRIALS research · 2026-04-16
  Clinical Trial Update: ICG (Indocyanine Green) Imaging Fluorescence Technology in Surgical Treatment of Advanced Gastric Cancer

  A clinical trial is recruiting to evaluate indocyanine green (ICG) fluorescence imaging technology in the surgical treatment of advanced gas…

• CLINICAL_TRIALS research · 2026-04-16
  Clinical Trial Update: Combination of TATE and PD-1 Inhibitor in Liver Cancer [Phase 2]

  Phase 2 clinical trial updating on the combination of TATE and a PD-1 inhibitor for hepatocellular carcinoma and gastric cancer, currently r…

• CLINICAL_TRIALS research · 2026-04-16
  Clinical Trial Update: PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer [Phase 2]

  Phase 2 clinical trial evaluating first-line gastric cancer treatment with a PD-1/TGF-β bispecific agent SHR-1701 in combination with SHR255…

• CLINICAL_TRIALS research · 2026-04-16
  Clinical Trial Update: Laparoscopic Staging for Stage III Gastric Cancer [NA]

  Ongoing clinical trial evaluating laparoscopic staging for stage III gastric cancer; the study is currently enrolling by invitation.

• FDA approval · 2026-04-15
  FDA Approved: ONTRUZANT — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for ONTRUZANT (trastuzumab) submitted by Organon LLC. The approval encompasses labeling updates rela…

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer [Phase 1]

  Phase 1 study evaluating paclitaxel for gastric cancer and gastroesophageal junction adenocarcinoma; the trial includes metastatic/stage IV …

• CLINICAL_TRIALS trial_result · 2026-04-15
  Clinical Trial Update: An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction Carcinoma [Phase 1, Phase 2]

  This Roche umbrella Phase 1/2 trial evaluating multiple treatment combinations in gastric and gastroesophageal junction carcinoma was termin…

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]

  Phase 1 clinical trial update for Enzelkitug as a single agent and in combination with a checkpoint inhibitor in adults with locally advance…

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]

  Phase 1 study evaluating oral MOMA-341 in adults with advanced or metastatic solid tumors, including endometrial, colorectal, and gastric ca…

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer [Phase 2]

  A Phase 2 clinical trial evaluating nivolumab and ipilimumab in combination with chemoradiation for resectable gastric cancer and gastroesop…

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer [Phase 2]

  A Phase 2 trial evaluating chemotherapy with or without radiation or surgery for oligometastatic gastric or esophageal cancer; the study is …